1. Home
  2. BLTE vs WGO Comparison

BLTE vs WGO Comparison

Compare BLTE & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • WGO
  • Stock Information
  • Founded
  • BLTE 2018
  • WGO 1958
  • Country
  • BLTE United States
  • WGO United States
  • Employees
  • BLTE N/A
  • WGO N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • BLTE Health Care
  • WGO Industrials
  • Exchange
  • BLTE Nasdaq
  • WGO Nasdaq
  • Market Cap
  • BLTE 1.7B
  • WGO 1.7B
  • IPO Year
  • BLTE 2022
  • WGO N/A
  • Fundamental
  • Price
  • BLTE $57.60
  • WGO $58.11
  • Analyst Decision
  • BLTE Strong Buy
  • WGO Buy
  • Analyst Count
  • BLTE 4
  • WGO 7
  • Target Price
  • BLTE $59.00
  • WGO $70.00
  • AVG Volume (30 Days)
  • BLTE 40.3K
  • WGO 458.3K
  • Earning Date
  • BLTE 11-12-2024
  • WGO 10-23-2024
  • Dividend Yield
  • BLTE N/A
  • WGO 2.34%
  • EPS Growth
  • BLTE N/A
  • WGO N/A
  • EPS
  • BLTE N/A
  • WGO 2.76
  • Revenue
  • BLTE N/A
  • WGO $3,023,600,000.00
  • Revenue This Year
  • BLTE N/A
  • WGO N/A
  • Revenue Next Year
  • BLTE N/A
  • WGO $9.07
  • P/E Ratio
  • BLTE N/A
  • WGO $21.02
  • Revenue Growth
  • BLTE N/A
  • WGO N/A
  • 52 Week Low
  • BLTE $31.01
  • WGO $49.68
  • 52 Week High
  • BLTE $57.82
  • WGO $75.42
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 83.16
  • WGO 49.52
  • Support Level
  • BLTE $55.63
  • WGO $56.05
  • Resistance Level
  • BLTE $56.37
  • WGO $60.88
  • Average True Range (ATR)
  • BLTE 1.65
  • WGO 1.62
  • MACD
  • BLTE 0.53
  • WGO 0.20
  • Stochastic Oscillator
  • BLTE 97.94
  • WGO 42.08

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was about $3.5 billion in fiscal 2023. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 79% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 39,447 in fiscal 2023. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: